PRADA, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 2.710
Totale 2.710
Nazione #
IT - Italia 2.710
Totale 2.710
Città #
Genova 1.707
Rapallo 451
Genoa 393
Vado Ligure 146
Bordighera 13
Totale 2.710
Nome #
Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation. 134
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 123
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 119
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 118
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 117
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype 115
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy 111
Sacral Nerve Stimulation for Fecal Incontinence in a Patient with Antiphospholipid Syndrome- Related Autonomic Neuropathy 110
Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? 104
Immunohistochemical evidnce of HLA-G expression in extravillous trophoblast invading decidual tissues. 103
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 103
Outcome measures in the clinical evaluation of ambulatory Charcot Marie Tooth 1A subjects 102
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 86
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 81
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 76
GAIN OR LOSS OF GLYCOSYLATION: THE SWEET SIDE OF MYELIN PROTEIN ZERO 75
Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study 70
Early detection of external neurological symptoms through a wearable smart-glasses prototype 70
Treadmill training in patients affected by Charcot-Marie-Tooth neuropathy: results of a multicenter, prospective, randomized, single-blind, controlled study 69
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 65
EARLY ONSET DEMYELINATING CHARCOT‐MARIE‐TOOTH DISEASE CAUSED BY A NOVEL IN‐FRAME ISOLEUCINE DELETION IN PERIPHERAL MYELIN PROTEIN 2 62
People with Charcot-Marie-Tooth disease and COVID-19: Impaired physical conditions due to the lockdown. An International cross-sectional survey 62
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 61
Comparison of Strength and Dexterity in Professional and Student Violinists: Setting Foundations to Guide Rehabilitation 58
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 58
A morphological reappraisal of Tubifex blanchardi Vejdovský, 1891 (Clitellata: Tubificidae) 51
Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years 51
Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease 48
High-dose immunoglobulin pulse therapy and risk of Covid19 infection 43
Distal motor neuropathy associated with novel EMILIN1 mutation 41
NeuroGlasses: A Wearable Prototype for Early Detection of Neurological Symptoms 41
The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical rehabilitation: the value of telerehabilitation for evaluation and continuing treatment 38
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 37
Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale 37
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 35
Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature 28
Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT 27
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 27
Techniques for the standard histological and ultrastructural assessment of nerve biopsies 10
Objective and subjective evaluation of walking ability with and without the use of a passive brace for hip flexor muscles in individuals with multiple sclerosis 7
Circadian rhythms and measures of CNS/autonomic interaction 6
TESTING OVERWORK WEAKNESS IN CHARCOT-MARIE-TOOTH (CMT) DISEASE: IS IT TRUE OR FALSE? 6
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 6
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis 6
Correction to: Robot‑assisted and traditional intensive rehabilitation therapy in the treatment of post‑acute stroke patient: the experience of a standard rehabilitation ward (Neurological Sciences, (2022), 43, 6, (3999-4001), 10.1007/s10072-022-06041-8) 5
OUTCOMES AFTER SINGLE-CYCLE RITUXIMAB MONOTHERAPY IN PATIENTS WITH ANTI-MAG ANTIBODY POLYNEUROPATHY: A 11 YEARS FOLLOW-UP ANALYSIS 5
MaM-36 and abilhand as outcome measures of multiple sclerosis hand disability: An observational study 5
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score 4
30-Second Chair Stand and 5-Times Sit-to-Stand Tests Are Interesting Tools for Assessing Disability and Ability to Ambulate among Patients with Multiple Sclerosis 4
Circadian Rhythms, Sleep, and Aging 3
Virtual Charcot-Marie-Tooth Examination Score: A Validated Virtual Evaluation for People with Charcot-Marie-Tooth Disease 3
Robot-assisted and traditional intensive rehabilitation therapy in the treatment of post-acute stroke patient: the experience of a standard rehabilitation ward 3
The role of sensory systems in the association between balance and walking in people with multiple sclerosis 3
Measures of CNS-autonomic interaction and responsiveness in disorder of consciousness 2
Totale 2.834
Categoria #
all - tutte 12.009
article - articoli 11.172
book - libri 0
conference - conferenze 837
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020647 0 0 18 48 60 83 103 60 76 105 63 31
2020/2021347 14 20 7 53 19 23 50 43 28 38 25 27
2021/2022416 16 23 22 34 18 30 20 91 30 54 18 60
2022/2023535 40 54 4 55 87 68 1 54 81 4 72 15
2023/2024307 18 24 7 48 22 66 23 21 19 5 22 32
2024/2025195 47 106 42 0 0 0 0 0 0 0 0 0
Totale 2.834